ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,388 | -62.2% | 1,200 | -44.3% | 0.00% | – |
| Q2 2023 | $30,130 | -1.1% | 2,156 | 0.0% | 0.00% | – |
| Q1 2023 | $30,461 | -32.3% | 2,156 | -35.9% | 0.00% | – |
| Q4 2022 | $45,000 | 0.0% | 3,366 | +2.6% | 0.00% | – |
| Q3 2022 | $45,000 | +80.0% | 3,280 | +58.5% | 0.00% | – |
| Q2 2022 | $25,000 | -34.2% | 2,070 | -27.9% | 0.00% | – |
| Q1 2022 | $38,000 | -75.0% | 2,870 | -66.6% | 0.00% | – |
| Q4 2021 | $152,000 | -56.4% | 8,594 | -21.9% | 0.00% | -100.0% |
| Q3 2021 | $349,000 | +134.2% | 11,002 | +531.6% | 0.00% | – |
| Q2 2021 | $149,000 | +27.4% | 1,742 | -58.5% | 0.00% | – |
| Q1 2021 | $117,000 | +108.9% | 4,200 | -43.2% | 0.00% | – |
| Q4 2020 | $56,000 | +47.4% | 7,396 | -5.6% | 0.00% | – |
| Q3 2020 | $38,000 | +1800.0% | 7,834 | +1743.3% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 425 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |